The force chain distributions of different numerical samples composed of elongated ellipsoids with different particle morphologies and particle sizes before shearing and after load... by Yongfeng Zhu (7361045)

Subjects:

The tangential force between two particles with different aspect ratios and sphericities for De = 6.30 mm: (a) elastic tangential contact force; (b) viscous tangential contact forc... by Yongfeng Zhu (7361045)

Subjects:

Critical state parameters obtained from DEM simulations. by Yongfeng Zhu (7361045)

Subjects:

The tangential force between two particles with different equivalent diameters for P3: (a) elastic tangential contact force; (b) viscous tangential contact force. by Yongfeng Zhu (7361045)

Subjects:

(A) Differences of gamma-aminobutyric acid (GABA)-related transcriptome between vehicle-treated <i>Angiostrongylus cantonensis</i>-infected mice and <i>Lactobacillus johnsonii</i>-... by Long Yin Lam (11172024)

Association between prenatal treatment and newborn characteristics. by Borja Guarch-Ibáñez (19929316)

Independent t-test and analysis of variance (ANOVA) results comparing quantitative data between dung faunas from Ivermectin-treated and untreated dung at the study area. by Shiret Belete (21100832)

Demographic parameters, comorbidities, and differences in clinical variables and laboratory parameters between AKD and non-AKD patients. by Vedran Premuzic (20188702)

Evolution of quality of life (SF-36 and CCVUQ) between T1 and T2 according to the study groups. by Mário Lins Galvão de Oliveira (20636431)

The regulation of CRE-Ter in dexamethasone (Dex)-treated C2C12 myotubes. by Sompot Jantarawong (22784041)

“…Statistical significance of the difference between CRE-Ter treated and untreated Dex-treated C2C12 myotubes is denoted as ^#<i>p</i> < 0.05. …”

Results of meta-regression analysis for the relationship between DPP-4is plus metformin versus SUs plus metformin on the risk of MACE. by Refli Hasan (20903188)

Results of meta-regression analysis for the relationship between DPP-4is plus metformin versus SUs plus metformin on the risk of mortality. by Refli Hasan (20903188)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects: